Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects
Clinical trial NCT04588727 · COMPLETED
Trial details
- NCT number
- NCT04588727
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2022-01-19
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.